loading
60 Degrees Pharmaceuticals Inc stock is traded at $0.919, with a volume of 14,801. It is up +2.45% in the last 24 hours and down -15.69% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$0.897
Open:
$0.87
24h Volume:
14,801
Relative Volume:
0.11
Market Cap:
$1.68M
Revenue:
$90,700
Net Income/Loss:
$-3.43M
P/E Ratio:
-0.565
EPS:
-1.6266
Net Cash Flow:
$-4.65M
1W Performance:
-7.17%
1M Performance:
-15.69%
6M Performance:
-65.95%
1Y Performance:
-88.98%
1-Day Range:
Value
$0.87
$0.938
1-Week Range:
Value
$0.865
$1.05
52-Week Range:
Value
$0.7015
$18.36

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Name
60 Degrees Pharmaceuticals Inc
Name
Phone
202-327-5422
Name
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Employee
2
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SXTP's Discussions on Twitter

Compare SXTP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SXTP 0.919 1.68M 90,700 -3.43M -4.65M -1.6266
VRTX 467.17 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.91 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 566.22 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.39 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.55 24.08B 3.30B -501.07M 1.03B 11.54

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

pulisher
Nov 15, 2024

60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 15, 2024
pulisher
Nov 15, 2024

60 Degrees Pharmaceuticals Reports 164% Sales Surge in Q3 2024, Driven by ARAKODA® Growth - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in 60 Degrees Pharmace - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

60 Degrees Pharma Reports 164% Revenue Surge, Doubles ARAKODA® Deliveries in Q3 | SXTPW Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 12, 2024

OptiNose (OPTN) Reports Break-Even Earnings for Q3 - Nasdaq

Nov 12, 2024
pulisher
Nov 07, 2024

60 Degrees Pharmaceuticals secures shareholder nods for key proposals - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

60 Degrees Pharmaceuticals secures shareholder nods for key proposals By Investing.com - Investing.com South Africa

Nov 07, 2024
pulisher
Nov 06, 2024

Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Compugen (CGEN) Stock Surges Amidst Biotech Sector Volatility - GuruFocus.com

Nov 06, 2024
pulisher
Oct 31, 2024

TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga

Oct 31, 2024
pulisher
Oct 15, 2024

SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow

Oct 15, 2024
pulisher
Oct 15, 2024

Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com

Oct 15, 2024
pulisher
Oct 14, 2024

Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN

Oct 14, 2024
pulisher
Oct 14, 2024

SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK

Oct 14, 2024
pulisher
Oct 11, 2024

Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN

Oct 11, 2024
pulisher
Oct 09, 2024

60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN

Oct 09, 2024
pulisher
Oct 05, 2024

60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks

Oct 05, 2024
pulisher
Oct 03, 2024

60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada

Oct 03, 2024
pulisher
Oct 03, 2024

60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times

Oct 03, 2024
pulisher
Oct 03, 2024

Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times

Oct 03, 2024
pulisher
Oct 02, 2024

Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com

Oct 02, 2024
pulisher
Sep 22, 2024

K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times

Sep 22, 2024
pulisher
Sep 21, 2024

Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office

Sep 21, 2024
pulisher
Sep 21, 2024

Ultraviolette set to export F77 sports bikes to European countries - Business Upturn

Sep 21, 2024
pulisher
Sep 20, 2024

Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Clinical Trials Arena

Sep 20, 2024
pulisher
Sep 19, 2024

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - EIN News

Sep 19, 2024
pulisher
Sep 19, 2024

Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday - The Economic Times

Sep 19, 2024
pulisher
Sep 18, 2024

Heavy Buying Alert: Multibagger IT-stock Hits Upper Circuits On September 18; Zooms 69 Per Cent From 52-Week Low! - Dalal Street Investment Journal

Sep 18, 2024
pulisher
Sep 17, 2024

100 films to be made in 48 hours - IOL

Sep 17, 2024
pulisher
Sep 15, 2024

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World

Sep 15, 2024
pulisher
Sep 12, 2024

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga

Sep 12, 2024
pulisher
Sep 11, 2024

60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada

Sep 11, 2024
pulisher
Sep 11, 2024

60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India

Sep 11, 2024
pulisher
Sep 11, 2024

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World

Sep 11, 2024
pulisher
Sep 06, 2024

SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan

Sep 06, 2024
pulisher
Sep 06, 2024

60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz

Sep 06, 2024
pulisher
Sep 06, 2024

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire

Sep 06, 2024
pulisher
Sep 06, 2024

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance

Sep 06, 2024
pulisher
Sep 05, 2024

60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN

Sep 05, 2024
pulisher
Sep 04, 2024

60 Degrees Pharmaceuticals announces private placement sale - Investing.com India

Sep 04, 2024
pulisher
Sep 04, 2024

60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks

Sep 04, 2024
pulisher
Sep 04, 2024

60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada

Sep 04, 2024
pulisher
Sep 04, 2024

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Sep 04, 2024
pulisher
Sep 02, 2024

60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex

Sep 02, 2024
pulisher
Aug 28, 2024

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire

Aug 28, 2024
pulisher
Aug 27, 2024

60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia

Aug 27, 2024
pulisher
Aug 27, 2024

60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia

Aug 27, 2024

60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
XU CHERYL
Director
May 16 '24
Option Exercise
0.22
2,000
446
228,934
FIELD PAUL
Director
May 16 '24
Option Exercise
0.22
4,000
892
14,000
DOW GEOFFREY S
President and CEO
Apr 12 '24
Option Exercise
0.27
68,000
18,142
745,625
DOW GEOFFREY S
President and CEO
May 16 '24
Option Exercise
0.22
17,000
3,791
762,625
Allen Charles W
Director
May 16 '24
Option Exercise
0.22
4,000
892
14,000
DOW GEOFFREY S
President and CEO
Jan 31 '24
Buy
0.38
25,974
9,740
703,599
XU CHERYL
Director
Jan 31 '24
Buy
0.38
200,000
75,000
424,934
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):